Keywords: USA, Grassley, Transparency, PMS, Medicare, Health reform, Pay-to-delay, GPhA

US Senator Grassley continues work for transparency of drug company money in medicine; patent settlement ban off House agenda?

Article | 18 March 2010

US Senator Charles Grassley (Republican, Iowa, and Ranking Member of the Committee on Finance) has asked leaders among pharmacy benefit ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in